• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

strategic partnership

Life raft
Biotech

Catamaran Bio sends out life raft in tough financing climate

Catamaran’s voyage is ending as the cell therapy biotech winds down and tries to find a new partner for its allogeneic solid tumor therapies.
Annalee Armstrong Jan 30, 2024 2:42pm
patients medicine doctor clinical trial practice physician

Velocity teams with Privia Health for clinical research sites

Jul 12, 2023 11:50am
Latin America south america

Medsir teams with Oncoclínicas in Latin America

Mar 31, 2022 3:35pm
Philips Zenition

Philips adds AI, 3D mapping to mobile X-ray platform

Jan 18, 2022 11:32am
Bristol Myers Squibb

Bristol Myers inks $3B in Century, ArsenalBio cell therapy deals

Jan 10, 2022 10:31am
A sheet of paper reading venture capital

Ncardia snags $60M to boost production of pluripotent stem cells

Nov 16, 2021 7:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings